CardiaTec
CardiaTec is a TechBio company that leverages a large-scale human cardiac tissue multiomics database to discover novel therapeutics for cardiovascular diseases. The company applies computational modeling to genomics, epigenomics, transcriptomics, and proteomics data sourced from a network of 65 hospitals in the UK and US. Spun out of the University of Cambridge, the platform aims to identify new drug targets by unravelling complex biological mechanisms driving disease progression.
Visit websiteCambridge, UK
Healthtech
Biotech
Artificial Intelligence
Drug Discovery
Funding summary
- Total raised
- €7.5M
- Funding rounds
- 2
Investors in CardiaTec
Investors on record for CardiaTec. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like CardiaTec?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors